Akums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Board Meeting ....
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Akums Drugs and Pharmaceuticals has informed exchanges that its Board Meeting is scheduled for 14th May 2026. The meeting will consider and approve the audited standalone and consolidated financial results for Q4 and full year ended 31st March 2026. The board will also consider recommending dividend for FY 2025-26. The trading window, which is currently closed, will reopen 48 hours after the declaration of these financial results. This is a routine regulatory intimation filed under SEBI listing regulations.
The announcement signals that annual FY2026 results will be declared shortly, which could impact the stock price positively if earnings meet expectations. Dividend recommendation adds potential investor interest. The company is NSE/BSE listed with symbol AKUMS and scrip code 544222.